| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | 0.075 | 0.2 |
| mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | -0.038 | 0.2 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | 0.045 | 0.2 |